BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26564738)

  • 1. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
    Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
    Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer-associated transcript 6 (PCAT6) promotes epithelial-mesenchymal transition and stemness and worsens prognosis in patients with colorectal cancer.
    Sun X; Yuan Y; Li S; Gan L; Xu M; Li Q; Liu M; Hu K; Nan K; Zhang J; Dong Y; Lin Y; Zhang X; Hou P; Liu T
    Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(6):866-878. PubMed ID: 38606479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance.
    Tsoumas D; Nikou S; Giannopoulou E; Champeris Tsaniras S; Sirinian C; Maroulis I; Taraviras S; Zolota V; Kalofonos HP; Bravou V
    Cancer Genomics Proteomics; 2018; 15(2):127-141. PubMed ID: 29496692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
    Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
    Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plastic persisters: revival stem cells in colorectal cancer.
    Tape CJ
    Trends Cancer; 2024 Mar; 10(3):185-195. PubMed ID: 38071119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dark force rising: Reawakening and targeting of fetal-like stem cells in colorectal cancer.
    Fey SK; Vaquero-Siguero N; Jackstadt R
    Cell Rep; 2024 May; 43(6):114270. PubMed ID: 38787726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.
    Han B; Qu Y; Jin Y; Yu Y; Deng N; Wawrowsky K; Zhang X; Li N; Bose S; Wang Q; Sakkiah S; Abrol R; Jensen TW; Berman BP; Tanaka H; Johnson J; Gao B; Hao J; Liu Z; Buttyan R; Ray PS; Hung MC; Giuliano AE; Cui X
    Cell Rep; 2015 Nov; 13(5):1046-58. PubMed ID: 26565916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAB2IP in cancer.
    Liu L; Xu C; Hsieh JT; Gong J; Xie D
    Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.
    Yao C; Su L; Shan J; Zhu C; Liu L; Liu C; Xu Y; Yang Z; Bian X; Shao J; Li J; Lai M; Shen J; Qian C
    Stem Cells; 2016 Apr; 34(4):820-31. PubMed ID: 26840943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients.
    Xie D; Liu L; Osaiweran H; Yu C; Sheng F; Gao C; Hu J; Gong J
    PLoS One; 2015; 10(11):e0142970. PubMed ID: 26566136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial mass and DNA repair in breast cancer stem cells.
    Pestell RG; Fatatis A; Jiao X
    Oncotarget; 2015 Nov; 6(36):38442-3. PubMed ID: 26564961
    [No Abstract]   [Full Text] [Related]  

  • 12. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.
    Bellazzo A; Di Minin G; Collavin L
    Cell Death Differ; 2017 Jan; 24(1):15-25. PubMed ID: 27858941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
    Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
    Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer statistics, 2020.
    Siegel RL; Miller KD; Goding Sauer A; Fedewa SA; Butterly LF; Anderson JC; Cercek A; Smith RA; Jemal A
    CA Cancer J Clin; 2020 May; 70(3):145-164. PubMed ID: 32133645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression.
    Pandya DV; Parikh RV; Gena RM; Kothari NR; Parekh PS; Chorawala MR; Jani MA; Yadav MR; Shah PA
    Mol Biol Rep; 2024 Jun; 51(1):701. PubMed ID: 38822973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle.
    Shah NN; Dave BP; Shah KC; Shah DD; Maheshwari KG; Chorawala MR; Parekh PS; Jani M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38502243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer.
    Huang Q; Zhang R; Xia Y; Shen J; Dong H; Li X; Tao D; Xie D; Liu L
    iScience; 2023 Sep; 26(9):107606. PubMed ID: 37664607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma.
    Yun EJ; Kim D; Kim S; Hsieh JT; Baek ST
    Cell Death Dis; 2023 Jul; 14(7):423. PubMed ID: 37443071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation.
    Xiong Z; Yang L; Li N; Fu J; Liu P; Sun P; Wei W; Xie X
    Clin Transl Med; 2022 Dec; 12(12):e1133. PubMed ID: 36536485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes.
    Day CA; Hinchcliffe EH; Robinson JP
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.